10-K Decoder · All companies

Tandem Diabetes Care, Inc.

TNDM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$1.01B$940M+7.9%
Operating income−$187M−$99.1M−88.9%
Net income−$205M−$96.0M−113%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$284M$249M+13.8%
Operating income−$2.40M−$22.9M+89.5%
Net income−$7.10M−$21.2M+66.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Tandem Diabetes's revenue in FY2025?
$1.01B in FY2025 (Fiscal year ended Dec 31, 2025), +7.9% vs $940M a year earlier, per its 10-K filed Feb 2026.
Was Tandem Diabetes profitable in FY2025?
No: net income was −$205M and operating income −$187M in FY2025.
What was Tandem Diabetes's revenue in Q3 2026?
$284M (+13.8% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.